List of works - Shyamal C Das

Agglomerate properties and dispersibility changes of salmeterol xinafoate from powders for inhalation after storage at high relative humidity.

scientific article published on 8 April 2009

Characterising surface energy of pharmaceutical powders by inverse gas chromatography at finite dilution

scientific article published on 09 May 2012

Characterization of the surface properties of a model pharmaceutical fine powder modified with a pharmaceutical lubricant to improve flow via a mechanical dry coating approach

scientific article published on 31 March 2011

Co-spray drying of hygroscopic kanamycin with the hydrophobic drug rifampicin to improve the aerosolization of kanamycin powder for treating respiratory infections

scientific article published on 16 February 2018

Considerations in preparing for clinical studies of inhaled rifampicin to enhance tuberculosis treatment

scientific article published on 03 July 2018

Determination of the Polar and Total Surface Energy Distributions of Particulates by Inverse Gas Chromatography

scientific article published on 21 December 2010

Dry powder formulation of kanamycin with enhanced aerosolization efficiency for drug-resistant tuberculosis

scientific article

Improving the de-agglomeration and dissolution of a poorly water soluble drug by decreasing the agglomerate strength of the cohesive powder.

scientific article

Influence of storage relative humidity on the dispersion of salmeterol xinafoate powders for inhalation

scientific article published in March 2009

Magnesium stearate increases salbutamol sulphate dispersion: what is the mechanism?

scientific article published on 11 September 2009

Manipulation of spray-drying conditions to develop dry powder particles with surfaces enriched in hydrophobic material to achieve high aerosolization of a hygroscopic drug

scientific article published on 4 April 2018

Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis.

scientific article published on 15 April 2016

Powder Strength Distributions for Understanding De-agglomeration of Lactose Powders

scientific article published on 14 June 2012

Simultaneous HPLC assay for pretomanid (PA-824), moxifloxacin and pyrazinamide in an inhaler formulation for drug-resistant tuberculosis

scientific article published on 25 November 2016

Surface Energy Determined by Inverse Gas Chromatography as a Tool to Investigate Particulate Interactions in Dry Powder Inhalers

scientific article published on 20 August 2015

Surface energy changes and their relationship with the dispersibility of salmeterol xinafoate powders for inhalation after storage at high RH.

scientific article published on 2 September 2009

The influence of lung surfactant liquid crystalline nanostructures on respiratory drug delivery

scientific article published on 16 June 2016

The influence of surface active l-leucine and 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC) in the improvement of aerosolization of pyrazinamide and moxifloxacin co-spray dried powders.

scientific article published on 7 March 2018

Understanding lactose behaviour during storage by monitoring surface energy change using inverse gas chromatography

Use of surface energy distributions by inverse gas chromatography to understand mechanofusion processing and functionality of lactose coated with magnesium stearate

scientific article

List of works by Shyamal C Das

Agglomerate properties and dispersibility changes of salmeterol xinafoate from powders for inhalation after storage at high relative humidity.

Characterising surface energy of pharmaceutical powders by inverse gas chromatography at finite dilution

Characterization of the surface properties of a model pharmaceutical fine powder modified with a pharmaceutical lubricant to improve flow via a mechanical dry coating approach

Co-spray drying of hygroscopic kanamycin with the hydrophobic drug rifampicin to improve the aerosolization of kanamycin powder for treating respiratory infections

Considerations in preparing for clinical studies of inhaled rifampicin to enhance tuberculosis treatment

Determination of the Polar and Total Surface Energy Distributions of Particulates by Inverse Gas Chromatography

Dry powder formulation of kanamycin with enhanced aerosolization efficiency for drug-resistant tuberculosis

Improving the de-agglomeration and dissolution of a poorly water soluble drug by decreasing the agglomerate strength of the cohesive powder.

Influence of storage relative humidity on the dispersion of salmeterol xinafoate powders for inhalation

Magnesium stearate increases salbutamol sulphate dispersion: what is the mechanism?

Manipulation of spray-drying conditions to develop dry powder particles with surfaces enriched in hydrophobic material to achieve high aerosolization of a hygroscopic drug

Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis.

Powder Strength Distributions for Understanding De-agglomeration of Lactose Powders

Simultaneous HPLC assay for pretomanid (PA-824), moxifloxacin and pyrazinamide in an inhaler formulation for drug-resistant tuberculosis

Surface Energy Determined by Inverse Gas Chromatography as a Tool to Investigate Particulate Interactions in Dry Powder Inhalers

Surface energy changes and their relationship with the dispersibility of salmeterol xinafoate powders for inhalation after storage at high RH.

The influence of lung surfactant liquid crystalline nanostructures on respiratory drug delivery

The influence of surface active l-leucine and 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC) in the improvement of aerosolization of pyrazinamide and moxifloxacin co-spray dried powders.

Understanding lactose behaviour during storage by monitoring surface energy change using inverse gas chromatography

Use of surface energy distributions by inverse gas chromatography to understand mechanofusion processing and functionality of lactose coated with magnesium stearate